LenioBio
LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
Dusseldorf, Germanywww.leniobio.com ↗
Total raised
€16M
€16,100,000
Funding rounds
3
Investors
3
distinct backers
Active since
2022-03
latest 2025-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood57
base rate 46% for Grant
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-28 | Grant | €3.7M | European Health and Digital Executive Agency (HaDEA) | View deal → |
| 2023-09-14 | Grant | €900k | EIT Food | View deal → |
| 2022-03-08 | Series A | €12M | Bridford Group | View deal → |
Related news
- LenioBio Closes €11.5M Series-A Extension Fundingfinsmes.com · 2022-03
- tech.eu
- finsmes.com
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software